+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

PDL BioPharma Inc (PDLI) - Financial and Strategic SWOT Analysis Review

  • ID: 1314909
  • SWOT Analysis
  • 50 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Audentes Therapeutics Inc
  • Dyax Corp
  • Genentech Inc
  • Genmab A/S
  • Gilead Sciences Inc
  • Ocera Therapeutics Inc
  • MORE
PDL BioPharma Inc (PDLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to late-stage public and private healthcare companies. PDL provides companies, academic institutions and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US.

PDL BioPharma Inc Key Recent Developments

Mar 20, 2019 PDL Community Bancorp Announces Results for the Year Ended December 31, 2018
Mar 14, 2019 PDL BioPharma reports 2018 fourth quarter and full year financial results
Nov 06, 2018 PDL BioPharma reports third quarter 2018 financial results
Oct 08, 2018 PDL BioPharma names Edward Imbrogno Vice President of Finance

Key Benefits

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Audentes Therapeutics Inc
  • Dyax Corp
  • Genentech Inc
  • Genmab A/S
  • Gilead Sciences Inc
  • Ocera Therapeutics Inc
  • MORE
Section 1 - About the Company
  • PDL BioPharma Inc - Key Facts
  • PDL BioPharma Inc - Key Employees
  • PDL BioPharma Inc - Key Employee Biographies
  • PDL BioPharma Inc - Major Products and Services
  • PDL BioPharma Inc - History
  • PDL BioPharma Inc - Company Statement
  • PDL BioPharma Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • PDL BioPharma Inc - Business Description
  • Business Segment: Income Generating Assets
  • Overview
  • Performance
  • Business Segment: Medical Devices
  • Overview
  • Performance
  • Business Segment: Pharmaceutical
  • Overview
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Rest of the World
  • Performance
  • Geographical Segment: United States
  • Performance
  • PDL BioPharma Inc - Corporate Strategy
  • PDL BioPharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • PDL BioPharma Inc - Strengths
  • PDL BioPharma Inc - Weaknesses
  • PDL BioPharma Inc - Opportunities
  • PDL BioPharma Inc - Threats
  • PDL BioPharma Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • PDL BioPharma Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 20, 2019: PDL Community Bancorp Announces Results for the Year Ended December 31, 2018
  • Mar 14, 2019: PDL BioPharma reports 2018 fourth quarter and full year financial results
  • Nov 06, 2018: PDL BioPharma reports third quarter 2018 financial results
  • Oct 08, 2018: PDL BioPharma names Edward Imbrogno Vice President of Finance
  • Aug 08, 2018: PDL BioPharma reports second quarter 2018 financial results
  • Jun 22, 2018: Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors
  • Jun 11, 2018: PDL BioPharma Appoints Shlomo Yanai As Board Director
  • May 21, 2018: PDL BioPharma Appoints Dr. Jill Jene As Vice President, Business Development
  • May 09, 2018: PDL BioPharma Announces First Quarter 2018 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • PDL BioPharma Inc, Key Facts
  • PDL BioPharma Inc, Key Employees
  • PDL BioPharma Inc, Key Employee Biographies
  • PDL BioPharma Inc, Major Products and Services
  • PDL BioPharma Inc, History
  • PDL BioPharma Inc, Subsidiaries
  • PDL BioPharma Inc, Key Competitors
  • PDL BioPharma Inc, Ratios based on current share price
  • PDL BioPharma Inc, Annual Ratios
  • PDL BioPharma Inc, Interim Ratios
  • PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • PDL BioPharma Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • PDL BioPharma Inc, Performance Chart (2014 - 2018)
  • PDL BioPharma Inc, Ratio Charts
  • PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Seattle Genetics Inc
  • Ocera Therapeutics Inc
  • Gilead Sciences Inc
  • Genmab A/S
  • Genentech Inc
  • Dyax Corp
  • Audentes Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll